Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

STT's $22.8m convertible bridge facility

11 Jan 2018 07:00

RNS Number : 5468B
Allied Minds PLC
11 January 2018
 

Update on Spin Transfer Technologies' $22.8 million convertible bridge facility

 

 

Boston MA - 11 January 2018 - Allied Minds (ALM: LSE) today announces that it has syndicated $10.28 million of the $22.8 million convertible bridge facility commitment it put in place for Spin Transfer Technologies (STT) in October 2017.

 

Existing STT shareholders Invesco Asset Management (Invesco) and Woodford Investment Management (WIM) will subscribe $10.28 million for convertible equity securities in STT, and Allied Minds commitment to the convertible bridge facility will be reduced by a corresponding amount to $12.52 million.

 

The facility is designed to bridge STT to the completion of a planned Series B funding round targeting strategic investors.

 

 

ENDS

 

For more information, please contact:

 

Allied Minds plc

Neil Pizey, Head of Corporate Development

+44 7771 872 922

FTI Consulting

Ben Atwell / Brett Pollard

+44 20 3727 1000

 

 

About Allied Minds

Based in Boston, Allied Minds plc is an IP commercialisation company focused on technology and life sciences. With extensive access to U.S. federal government laboratories and universities, as well as partnerships with leading U.S. corporations, Allied Minds forms, funds, and operates a portfolio of companies with the objective of delivering successful liquidity events that will generate attractive long-term returns for its investors and stakeholders. Allied Minds supports its businesses with capital, resources, and expertise.

For more information, please visit www.alliedminds.com

 

About STT

Spin Transfer Technologies, Inc. (STT) is seeking to develop ST-MRAM technologies that uniquely combine patented magnetics technologies, circuits and memory architectures to create the industry's lowest-cost, highest-performance ST-MRAM memories. STT's disruptive ST-MRAM solutions are ideal replacements for embedded and stand-alone SRAMs as well as future DRAM devices, affecting more than half of the $300+ billion semiconductor industry. The company was established by Allied Minds and New York University. For more information, please visit www.spintransfer.com.

 

Further information on the fund-raise

Of the $10.28 million STT convertible equity securities subscribed, Invesco contributed $6.0 million for the purchase of 600 securities and WIM contributed $4.28 million for the purchase of 428 securities Both Invesco and WIM are substantial shareholders of Allied Minds pursuant to the Listing Rules and thus, this transaction is a smaller related party transaction falling within the scope of Listing Rule 11.1.10R.

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKKDKFBKDBDD
Date   Source Headline
9th Feb 20164:35 pmRNSPrice Monitoring Extension
9th Feb 20167:00 amRNSTrading Statement
4th Feb 20163:15 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSAllied Minds Subsidiary Produces Prototype
1st Feb 20167:00 amRNSAllied Minds Subsidiary Raises $22 million
15th Jan 20167:00 amRNSDirectorate Change
11th Jan 20165:31 pmRNSHolding(s) in Company
7th Jan 20164:57 pmRNSBlocklisting Six Monthly Return
3rd Nov 20153:55 pmRNSTotal Voting Rights
28th Oct 201510:53 amRNSHolding(s) in Company
13th Oct 20154:53 pmRNSHolding(s) in Company
12th Oct 20152:58 pmRNSHolding(s) in Company
5th Oct 20157:00 amRNSPrecision Biopsy Raises $33.6 Million
23rd Sep 20157:00 amRNSFederated Wireless NASCTN first pilot test
17th Sep 20157:00 amRNSFormation of HawkEye 360
4th Sep 20154:19 pmRNSDirectorate Change
1st Sep 20157:03 amRNSAllied Minds Names Joseph Pignato as CFO
27th Aug 20157:04 amRNSHalf Yearly Report
27th Aug 20157:01 amRNSABLS Licenses Technology and Molecules from Yale
25th Aug 20154:24 pmRNSAppointment of New Senior Independent Director
31st Jul 20153:02 pmRNSTotal Voting Rights
30th Jun 20159:37 amRNSTotal Voting Rights
26th Jun 20155:16 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSABLS licenses IP from Harvard
10th Jun 20155:06 pmRNSBlocklisting Six Monthly Return
5th Jun 20157:30 amRNSLong Term Incentive Plan
5th Jun 20157:00 amRNSAppointment of Kevin Sharer to Board of Directors
28th May 20156:06 pmRNSResult of AGM
28th May 20157:00 amRNSAGM Statement
22nd May 20154:07 pmRNSHolding(s) in Company
21st May 20152:17 pmRNSHolding(s) in Company
20th May 20157:33 amRNSResults of Placing
28th Apr 201512:00 pmRNSCapital Markets Day
28th Apr 20157:31 amRNSAnnual Results Release
28th Apr 20157:00 amRNSAppointment of New Non-Executive Chairman
22nd Apr 20157:00 amRNSSciFluor Life Sciences Raises $30 Million
2nd Apr 20153:40 pmRNSHolding(s) in Company
1st Apr 20154:33 pmRNSTotal Voting Rights
26th Mar 20152:30 pmRNSNotice of Results and Capital Markets Day
20th Mar 20154:35 pmRNSPrice Monitoring Extension
10th Mar 20157:02 amRNSAllied Minds Announces the Formation of BridgeSat
3rd Feb 20154:06 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
4th Dec 20147:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
19th Nov 201410:03 amRNSBlock Listing of Shares
12th Nov 20147:00 amRNSAllied Minds Appointment of Joint Broker
5th Nov 20147:00 amRNSAllied Minds Appoints Donna See as Vice President
30th Oct 20147:00 amRNSAllied Minds forms Seamless Devices, Inc.
20th Oct 20143:12 pmRNSHolding(s) in Company
9th Oct 201410:11 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.